Revolution Medicines Inc

NASDAQ:RVMD   3:59:47 PM EDT
43.67
-0.30 (-0.68%)
Earnings Announcements

Revolution Medicines Reports Third Quarter 2020 Financial Results And Update On Corporate Progress

Published: 11/12/2020 12:45 GMT
(RVMD) - Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress.
Revolution Medicines Inc - Qtrly Loss per Share $0.42.
Revolution Medicines Inc - Qtrly Total Revenue $12.7 Million Versus $12.5 Million.
Revenue is expected to be $16.78 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $12.67 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.